This may be closely related to AKR1B10’s aldose reductase activity, whose protumorigenic effects are attenuated upon inhibition of the inflammatory factors IL-1α and IL-6, thereby inhibiting tumor cell growth. Here, AKR1B10 is linked to neoplasm.